488 related articles for article (PubMed ID: 25450711)
1. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma.
Yeung OW; Lo CM; Ling CC; Qi X; Geng W; Li CX; Ng KT; Forbes SJ; Guan XY; Poon RT; Fan ST; Man K
J Hepatol; 2015 Mar; 62(3):607-16. PubMed ID: 25450711
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated macrophage or chemokine ligand CCL17 positively regulates the tumorigenesis of hepatocellular carcinoma.
Zhu F; Li X; Chen S; Zeng Q; Zhao Y; Luo F
Med Oncol; 2016 Feb; 33(2):17. PubMed ID: 26781124
[TBL] [Abstract][Full Text] [Related]
4. M2 macrophages on tumour growth and metastasis in hepatocellular carcinoma.
Man K; Lo CM; Liu XB
Hong Kong Med J; 2019 Dec; 25 Suppl 9(6):35-39. PubMed ID: 31889034
[No Abstract] [Full Text] [Related]
5. Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment.
Li Q; Ma L; Shen S; Guo Y; Cao Q; Cai X; Feng J; Yan Y; Hu T; Luo S; Zhou L; Peng B; Yang Z; Hua Y
J Exp Clin Cancer Res; 2019 Jul; 38(1):303. PubMed ID: 31296243
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice.
Huang W; Chen Z; Zhang L; Tian D; Wang D; Fan D; Wu K; Xia L
Gastroenterology; 2015 Oct; 149(4):1053-67.e14. PubMed ID: 26065367
[TBL] [Abstract][Full Text] [Related]
7. SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARδ signalling-mediated alternative activation of macrophages.
Li Z; Li H; Zhao ZB; Zhu W; Feng PP; Zhu XW; Gong JP
J Exp Clin Cancer Res; 2019 Nov; 38(1):469. PubMed ID: 31744516
[TBL] [Abstract][Full Text] [Related]
8. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.
Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ
J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401
[TBL] [Abstract][Full Text] [Related]
9. Elevated CD163
Yang C; Wei C; Wang S; Shi D; Zhang C; Lin X; Dou R; Xiong B
Int J Biol Sci; 2019; 15(5):984-998. PubMed ID: 31182919
[No Abstract] [Full Text] [Related]
10. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA
Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Xu M; Zhen L; Lin L; Wu K; Wang Y; Cai X
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):340-348. PubMed ID: 31422034
[TBL] [Abstract][Full Text] [Related]
12. Association of tumour-associated macrophages with cancer cell EMT, invasion, and metastasis of Kazakh oesophageal squamous cell cancer.
Liu J; Li C; Zhang L; Liu K; Jiang X; Wang X; Yang L; Liang W; Liu K; Hu J; Li F
Diagn Pathol; 2019 Jun; 14(1):55. PubMed ID: 31186031
[TBL] [Abstract][Full Text] [Related]
13. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
14. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
[TBL] [Abstract][Full Text] [Related]
15. CD68(+)HLA-DR(+) M1-like macrophages promote motility of HCC cells via NF-κB/FAK pathway.
Wang H; Wang X; Li X; Fan Y; Li G; Guo C; Zhu F; Zhang L; Shi Y
Cancer Lett; 2014 Apr; 345(1):91-9. PubMed ID: 24333724
[TBL] [Abstract][Full Text] [Related]
16. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH
Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469
[TBL] [Abstract][Full Text] [Related]
17. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.
Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y
Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
Chang RM; Xu JF; Fang F; Yang H; Yang LY
Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
[TBL] [Abstract][Full Text] [Related]
19. ZnAs@SiO
Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
[No Abstract] [Full Text] [Related]
20. Sorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretion.
Sprinzl MF; Puschnik A; Schlitter AM; Schad A; Ackermann K; Esposito I; Lang H; Galle PR; Weinmann A; Heikenwälder M; Protzer U
J Hepatol; 2015 Apr; 62(4):863-70. PubMed ID: 25463538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
